MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$1,989,333
EPS
-$0.09
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
1,285,942 1,118,649 993,066 1,387,275.25*
General and administrative
744,276 1,114,525 803,619 1,010,636*
Total operating expenses
2,030,218 2,233,174 1,796,685 2,397,911.25
Loss from operations
-2,030,218 -2,233,174 -1,796,685 -2,397,911.25*
Interest income
40,885 12,455 11,627 31,207*
Interest expense
---37.25*
Other income, net
40,885 12,455 11,627 31,169.75*
Net loss
-1,989,333 -2,220,719 -1,785,058 -2,366,741.5
Basic EPS
-0.09 -0.11 -0.1 -0.157
Diluted EPS
-0.09 -0.11 -0.1 -0.157
Basic Average Shares
21,609,488 19,850,080 17,082,425 15,116,548
Diluted Average Shares
21,609,488 19,850,080 17,082,425 15,116,548
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$40,885 Net loss-$1,989,333 Other income, net$40,885 Loss from operations-$2,030,218 Total operatingexpenses$2,030,218 Research and development$1,285,942 General andadministrative$744,276

NANOVIRICIDES, INC. (NNVC)

NANOVIRICIDES, INC. (NNVC)